GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Northfield Laboratories Inc. (NFLD) [hlAlert]

Rating:
Sell NFLD
up 1,163.63 %

Northfield Laboratories Inc. (NFLD) rated Sell

Posted on: Tuesday,  Jul 3, 2007  9:25 AM ET by Morgan Joseph

Morgan Joseph rated Sell Northfield Laboratories Inc. (NASDAQ: NFLD) on 07/03/2007, when the stock price was $1.39. Since
then, Northfield Laboratories Inc. has lost 92.09% as of 06/10/2009's recent price of $0.11.
If you would have followed this Morgan Joseph's recommendation on NFLD, you would have gained 1163.63% of your investment in 708 days.

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. PolyHeme is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types.

Morgan Joseph is committed to providing timely, objective and actionable investment advice on the companies and securities we follow. Our team of equity analysts covers a growing universe of stock issues across a broad range of industry sectors. As a middle market-focused firm, our approach is not to publish research on as many companies as possible within a number of industry sectors. Rather, our research analysts distinguish themselves by zeroing in on quality companies with growth prospects or which present special situations. These companies often lack a research following. This enables our analysts to provide insight to investors in companies that are not well understood nor fairly valued.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/3/2007 9:25 AM Sell
None
1.39
as of 9/8/2009
1 Week   
1 Month   
3 Months up  50.00 %
1 YTD up  88.88 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy